Barrett's patients who smoke twice as likely to develop oesophageal cancer

Smoking doubles the risk of developing oesophageal cancer in people with Barrett's Oesophagus, according to scientists at Queen's University Belfast and the Northern Ireland Cancer Registry.

Affecting one in every 100 people in the UK, Barrett's Oesophagus is a disorder in which the lining of the oesophagus is damaged by and is changed to a lining similar to that of the stomach.

The research, published in Gastroenterology, the official journal of the American Gastroenterological Association, was carried out over 13 years and involved over 3000 Barrett's patients. It found that those who smoked tobacco were twice as likely to develop of the oesophagus, than those who did not.

Dr Helen Coleman from the Centre for Public Health in Queen's School of Medicine, Dentistry and Biomedical Sciences led the study. She said: "We found that emerged as the strongest lifestyle risk factor for for patients with Barrett's Oesophagus. The risk of developing this cancer doubled for those who were smoking tobacco. One of the most interesting observations was that someone who smoked less than one pack a day was still as likely to develop cancer as those who smoked many more."

The study was the first of its kind worldwide in terms of size by taking a sample of over 3000 patients. Researchers were able to get information about smoking at the time a person was first diagnosed with Barrett's Oesophagus to see how this influenced cancer risk years later. This is important for reducing bias known to be associated with asking patients about their smoking habits in the past.

Although these findings need to be confirmed in future studies, the study's researchers suggest that tobacco smoking should be discouraged and smoking-cessation strategies considered in Barrett's Oesophagus patients in order to reduce future .

Provided by Queen's University Belfast

not rated yet

Related Stories

New hope for therapy in heartburn-related cancer

Jan 12, 2010

A new study published in the journal Disease Models and Mechanisms shows that DBZ, a drug currently in clinical trials for use in the treatment of Alzheimer's disease, is able in rats to stop the growth of Barrett's esophagus, ...

Recommended for you

Americans undergo colonoscopies too often, study finds

14 hours ago

Colonoscopies are a very valuable procedure by which to screen for the presence of colorectal cancer. However, it seems that healthy Americans who do undergo this sometimes uncomfortable examination often ...

User comments

Adjust slider to filter visible comments by rank

Display comments: newest first

tadchem
not rated yet Jan 31, 2012
One could search for (and find) statistical associations between This and That for several lifetimes, but this would shed little, if any, enlightenment on the causes of disease,
especially when the chi-squared statistics of rare events are ignored by using 'ratio comparisons' and such.
The causes themselves must be found if the diseases are ever to be cured.